Brett Noerager

Title: Brett Noerager: Innovator in Neutrophilic Inflammation Research

Introduction

Brett Noerager is a notable inventor based in Birmingham, Alabama. He has made significant contributions to the field of medical research, particularly in the area of neutrophilic inflammation. His work focuses on developing methods to reduce or prevent this type of inflammation, which can have serious health implications.

Latest Patents

Brett Noerager holds a patent for "Prolyl endopeptidase inhibitors for reducing or preventing neutrophilic inflammation." This patent outlines methods for selecting subjects at risk for neutrophilic inflammation and administering agents that inhibit the expression or activity of prolyl endopeptidase. The patent aims to provide treatment or prevention for diseases associated with neutrophilic inflammation. He has 1 patent to his name.

Career Highlights

Brett Noerager is affiliated with the UAB Research Foundation at the University of Alabama at Birmingham. His work at this institution has allowed him to explore innovative solutions to complex medical challenges. His research has the potential to impact the treatment of various inflammatory diseases.

Collaborations

Some of his notable coworkers include J Edwin Blalock and Uros V Djekic. Their collaborative efforts contribute to the advancement of research in the field of inflammation and related diseases.

Conclusion

Brett Noerager is a dedicated inventor whose work in neutrophilic inflammation research is paving the way for new treatment methods. His contributions are significant in the medical field, and his patent reflects his commitment to improving health outcomes.